Whitehawk Therapeutics, Inc.
WHWK· Nasdaq
Released Mar 17, 2022, before the open
10-K filed Mar 17, 2022, 76 days after period end · 0001564590-22-010721
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $13.88M | — | — | $2.14K |
| Net Income | -$15.99M | $8.02M | -$4.45M |
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
| -$8.52M |
| EPS Diluted | — | — | -$0.11 | -$0.21 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.